$HSGX: Histogenics’ (HSGX) CEO Adam Gridley on Q3 2018 Results …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Histogenics Corporation (NASDAQ:HSGX) Q3 2018 Earnings Conference Call November 8, 2018 8:30 AM ET. Executives. Jon Lieber – Chief Financial Officer.

Full article address: https://seekingalpha.com/article/4220807-histogenics-hsgx-ceo-adam-gridley-q3-2018-results-earnings-call-transcript

Related News:

$HSGX $MRK: The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical …

$HSGX: Histogenics up 8% premarket

$HSGX: Histogenics slips 4% after hours on delist notice

$HSGX: Histogenics nets $15.4M in equity offering

$HSGX: Histogenics down 41% on pricing public offering of common stock …

$HSGX: Histogenics Corporation Announces Pricing of Public Offering of …

Latest News:

$DWDP: Is DowDuPont a Buy?

$T $VIA: Viacom and AT&T Negotiate to Avert Major Programming Blackout

$MGM $CZR $VICI: How Wynn Resorts Could Free Up Billions in Cash

$PYX $RKDA: CBD is booming. But US farmers struggle to keep up with demand for industrial hemp

$GE: 3 Stocks Looking to Benefit From GE’s Misfortunes

$LEVI: Before the Levi’s IPO, there was the 1985 buyout led by iconoclastic S.F. investor Warren Hellman

$TLRY $CGC: 1 Figure That Guarantees a Canadian Marijuana Oversupply Is …

$AAPL $GS: Steve Jobs was trying to revolutionize TV almost a decade ago — now we’ll find out Apple’s plan

$SBUX: Starbucks Increasing its Environmental Commitment

$GH $ROKU: 3 Stocks That Are Up More Than 100% in 2019

$SUN: Is Sunoco a Buy?